期刊文献+

冠心病患者血清胆红素与尿酸的检验价值分析 被引量:6

下载PDF
导出
摘要 目的分析冠心病患者血清胆红素与尿酸的检验价值。方法随机选取冠心病患者45例作为研究组,并选取同时期于本院行健康体检的健康者30例作为对照组,对比两组的血清胆红素与尿酸水平,并依据冠心病患者的Gensini积分对比分析不同程度病情患者的血清胆红素与尿酸水平。结果研究组的间接胆红素、直接胆红素、总胆红素均低于对照组,尿酸水平高于对照组,差异具有统计学意义(P<0.05);随着病情的进展与Gensini积分的增加,冠心病患者的血清胆红素逐渐下降,而尿酸水平呈现上升趋势,对比差异具有统计学意义(P<0.05)。结论血清胆红素与尿酸水平有助于冠心病的早期诊断,并有效评估冠动脉的狭窄程度。
作者 路艳
出处 《中国实用医药》 2015年第13期75-76,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献40

  • 1刘会田,杜戎,吕学祥,任法鑫,袁国会.冠心病患者血清胆红素及尿酸水平的变化[J].心血管康复医学杂志,2005,14(3):226-227. 被引量:15
  • 2李燕萍,郭秀兰,徐岩,徐长丽,杨晓霞.血清胆红素、尿酸、血脂与冠心病关系的研究[J].宁夏医学杂志,2007,29(9):792-794. 被引量:3
  • 3李国宏.冠心病患者胆红素、尿酸、血脂水平及其临床意义[J].临床和实验医学杂志,2010,9(6):425-426.
  • 4Erkan A, Ekici B, Ugurlu M, et al. The role of bilirubin and its protective function against coronary heart disease[J]. Herz,2013. [Epub ahead of print].
  • 5Yang XF , Chen YZ, Su JL, et al. Relationship between serum bilirubin and carotid atherosclerosis in hypertensive patients [J]. Intern Med, 2009,48(18) :1595-1599.
  • 6Sinan UY, Canbolat IP, Baydar O, et al. Relationship Between Increased Serum Resistin Level and Severity of Coronary Artery Disease [J] . Angiology, 20 13. [Epub ahead of print].
  • 7Wei S,Mao L,Liu B,et al. Serum biomarkers and the prognosis of AMI patients [J]. Herz,2013. [Epub ahead of print].
  • 8Che J , Li G, Wang W , et al. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score [J]. Cardiol J, 2011 ,18 (4) :364-370.
  • 9Kamisako T , Masuda S, Tanaka Y. Relationship between serum bilirubin and remnant lipoprotein cholesterol level [J]. Clin Lab, 2013 ,59 (34) :435-438.
  • 10Tiwari S, Ndisang JF. Heme Oxygenase system and hypertension: a comprehensive insight [J]. Curr Pharm Des, 2013. [Epub ahead of print].

共引文献55

同被引文献30

  • 1王华忠.血清胆红素与尿酸检验在冠心病患者诊断中的临床价值分析[J].医学信息(医学与计算机应用),2014,0(25):269-269. 被引量:4
  • 2鲁祖建,易剑明.冠心病患者血清胆红素与血尿酸及血脂水平关系的研究[J].中国医师杂志,2005,7(4):555-556. 被引量:10
  • 3刘振兵,刘晓方.慢性心力衰竭患者血尿酸水平和肾功能变化的研究[J].宁夏医学杂志,2006,28(8):574-575. 被引量:9
  • 4丁振若,于文彬,苏明权,等.现代检验医学[M].北京:人民军医出版社,2007:17.
  • 5Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study [ J]. Ann Intern Med, 1999,131 ( 1 ) :7-13.
  • 6Fang J, Aldemran MH." Serum uric acid and cardiovascular mortal- ity the NHANES I epidemiologic follow-up study, 1971-1992. Na- tional Health and Nutrition Examination Survey[J]. JAMA,2000, 283 ( 18 ) :2404-2410.
  • 7Schwertner HA, Jackson WG, Tolan G. Association of low serum- concentration of bilirubin with increased risk of coronary artery dis- ease[ J]. Clin Chem,1994,40( 1 ) : 18-23.
  • 8Wang X, Wang Y, Kim HP, et al. Carbon monoxide protects a- gainst hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation [ J ]. J Biol Chem, 2007,282 (3) :1718-1726.
  • 9Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure Assessment of Reduction in Mortali-ty and Morbidity (CHARM) program [ J ]. Eur J Heart Fai| ,2009, 11 (2) :170-177.
  • 10Olexa P, Olexovt M, Gonsorcik J , et al. Uric acid--a marker for systemic inflammatory response in patients with congestive heart failure? [ J ]. Wien Klin Wochenschr, 2002, 114 ( 5-6 ) : 211- 215.

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部